Organogenesis Holdings Inc.

Ticker ORGO

Exchange NASDAQ More
Industry Drug Manufacturers - Other More
Sector Healthcare More

501-1000 Employees
Based in Canton, Massachusetts

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

Visit website

REPORT RATINGS

4.7 / 5.0 (96)

Organogenesis Holdings Inc. reports have an aggregate usefulness score of 4.7 based on 96 reviews.

Organogenesis Holdings Inc.